English

Eye infections from Franck Pharmacy's 'Brilliant Blue G' begs 2nd FDA warning.

Report this content

Since the U.S. Food and Drug Administration (FDA) issued a warning to doctors on March 19, the agency received additional reports of eye infections in patients who were given Franck Pharmacy’s Brilliant Blue G (BBG) during eye surgery.

Clinicians in several states also reported to the agency that patients who were given injections of the drug products containing triamcinolone during eye surgery experienced eye infections.

Brilliant Blue G is not approved in the U.S. by the FDA and its manufacturer recalled all lots of BBG and one lot of Triamcinolone Acetonide P.F., according to a press release by the agency. The Centers for Disease Control and Prevention (CDC), the FDA as well as local and state public health agencies are actively investigating these incidents.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you. Call us today at (877) 490-6520.

Tags:

Sokolove Law Franck Pharmacy Brilliant Blue G BBG

Quick facts

Eye infections from Franck Pharmacy's 'Brilliant Blue G' begs 2nd FDA warning.
Tweet this